Lion's Mane for Seniors: The Strongest Human Evidence

Written by Peter Orpen, reviewed by the Teelixir Research Team · Updated: 27 March 2026 · Evidence Grade: Good

Of every population studied for lion's mane (Hericium erinaceus) benefits, older adults have the most evidence. This is not a marketing claim — it is where the clinical trials focused first, and where the results have been most consistent across independent research groups.

The landmark 2009 Mori trial recruited adults aged 50–80 with mild cognitive impairment (MCI). A 2019 Japanese study used adults with a mean age of 61. An Alzheimer's pilot ran for 49 weeks — nearly a year — in early-stage patients. The 2025 systematic review that pooled all cognitive RCTs found a combined weighted mean MMSE improvement of 1.17 points in the lion's mane groups (PMID: 40959699).

If you or a family member are navigating age-related cognitive changes, this is the most relevant article in our lion's mane series.

Why Seniors? The Biological Rationale

Two neurotrophic factors — nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) — are central to maintaining cognitive function. Both decline measurably with age.

NGF supports the survival and function of cholinergic neurons — precisely the cell population that deteriorates in Alzheimer's disease. BDNF supports hippocampal plasticity: the brain's ability to form and retain new memories. When both decline together, as they do from middle age onwards, the result is the gradual cognitive slowing that many people notice from their 50s.

Lion's mane addresses this directly. Its fruiting body contains hericenones, and its mycelium contains erinacines — two chemically distinct compound classes that both stimulate NGF production through different pathways. Erinacines are small enough to cross the blood-brain barrier, making them particularly relevant for neurological applications. A 2025 systematic review of erinacine research across preclinical models found consistent evidence of neuroprotective effects, antioxidant activation, and improved cognitive and behavioural outcomes (PMID: 40626304).

This is mechanistically coherent: lion's mane is not masking symptoms. It is supporting the biological infrastructure that allows neurons to survive, connect, and function.

The Landmark Mori Study (2009): Mild Cognitive Impairment

The most-cited lion's mane clinical trial was published in Phytotherapy Research by Mori and colleagues. It recruited 30 Japanese men and women aged 50–80, all with confirmed mild cognitive impairment (MCI). MCI is clinically significant: it represents measurable cognitive decline beyond what is expected for age, and carries a substantially elevated risk of progression to Alzheimer's disease.

The trial was double-blind and placebo-controlled. Participants in the active arm took 3 g of lion's mane fruiting body powder daily (four 250 mg tablets, three times daily) for 16 weeks (PMID: 18844328).

Results: The lion's mane group showed significantly increased cognitive function scores on the Revised Hasegawa Dementia Scale (HDS-R) compared to placebo at weeks 8, 12, and 16. Scores climbed progressively over the supplementation period, rising from approximately 22–25 at baseline to approximately 30 by week 16. The placebo group showed no such improvement.

Critical caveat: After the supplementation period ended, cognitive scores declined significantly back toward baseline within four weeks. This finding is important and honest: lion's mane appears to support ongoing cognitive function rather than permanently reversing decline. Continuous supplementation seems to be required to maintain the benefit.

The Saitsu Study (2019): Everyday Memory in Older Adults

Published in the Journal of Integrative Medicine Reports, this RCT took a different approach: instead of tablets, participants received lion's mane in cookie form — making it a practical, real-world-style trial. Thirty-one participants with a mean age of 61.3 years consumed 0.8 g of lion's mane fruiting body daily for 12 weeks. Cognitive function was assessed using the Mini-Mental State Examination (MMSE) (PMID: 31413233).

Results: The lion's mane group showed statistically significant improvement in MMSE scores compared to placebo, with particular gains in short-term memory and cognitive processing. No adverse effects were reported.

The dose here — 0.8 g daily — is notably lower than the Mori study's 3 g. Yet benefits were still measurable. This suggests that even modest supplementation may meaningfully support cognitive function in older adults. It also raises the hypothesis that dose-response may differ between individuals and conditions.

The Alzheimer's Prevention Pilot: 49 Weeks of Erinacine A

A pilot double-blind, placebo-controlled study tested erinacine A-enriched Hericium erinaceus mycelium capsules in patients with early-stage Alzheimer's disease over 49 weeks — nearly a full year of supplementation (PMID: 32394131).

Participants in the active group showed improvements in cognitive assessments and activities of daily living scores compared to placebo. The long duration of this trial is particularly notable: it is the only lion's mane study to approach a year of follow-up, and benefits were sustained rather than plateauing.

It is worth being clear about the distinction in this study: the active ingredient was erinacine A from mycelium, not hericenones from fruiting body. Teelixir's extract uses 100% fruiting body (dual-extracted), which contains hericenones rather than erinacines. Both compound classes stimulate NGF through different but complementary pathways. The mechanistic rationale for benefit applies to both; however, this specific trial used mycelium.

The BDNF Elevation Study: Mood, Sleep, and Neural Growth

A 2019 study investigated lion's mane supplementation in overweight adults — a population that often includes older individuals and is known to have elevated inflammation and depressed neurotrophic factor levels (PMID: 30934743).

Eight weeks of supplementation significantly increased both pro-BDNF and mature BDNF levels compared to placebo. Participants also showed improvements in mood and sleep quality alongside the BDNF elevation. This is mechanistically important for ageing brains: BDNF supports hippocampal neurogenesis and synaptic plasticity — the processes that underpin memory formation and retrieval.

The 2025 Systematic Review: Pooling All the Evidence

A 2025 PRISMA-registered systematic review published in Frontiers in Nutrition synthesised all published RCTs and pilot clinical trials of Hericium erinaceus supplementation in humans (PMID: 40959699). This is the most comprehensive human evidence synthesis to date.

Cognitive findings: MMSE scores from one RCT (Saitsu 2019) and one pilot clinical trial (Li 2020) showed a combined weighted mean increase of 1.17 points in the intervention groups. A 1-point MMSE change is considered clinically meaningful in MCI populations.

The review also documented benefits across multiple systems:

• Enhanced pro-BDNF and mature BDNF production
• Promotion of hippocampal neurogenesis
• Increased gut microbiota diversity with elevated SCFA-producing bacteria (reducing systemic inflammation)
• Reduced symptoms of depression, anxiety, and sleep disturbance
• Favourable safety profile across all trials — stomach discomfort, headache, and mild allergic reactions were occasionally reported but uncommonly

The Gut–Brain Connection: An Underappreciated Pathway

Cognitive ageing is increasingly understood as a systemic process, not purely a brain event. Chronic low-grade inflammation — sometimes called "inflammageing" — is a major driver of neurodegeneration. Much of this inflammation originates in the gut, via a dysbiotic microbiome that produces fewer short-chain fatty acids (SCFAs) and more inflammatory signals.

The 2025 systematic review documented a clinically relevant finding here: lion's mane supplementation increased the diversity and abundance of SCFA-producing gut bacteria (PMID: 40959699). SCFAs such as butyrate cross the gut-brain barrier, reduce neuroinflammation, and support the integrity of the blood-brain barrier itself. This gut-brain pathway may help explain why lion's mane benefits extend beyond direct NGF/BDNF stimulation to include mood, sleep, and broader cognitive function.

For seniors, this is particularly relevant: gut microbiome diversity typically declines with age. Lion's mane may partially address this decline while simultaneously supporting neurotrophin production — two complementary mechanisms acting in parallel.

Honest Limitations: What the Science Does Not Yet Show

We think it is important to be straightforward about the state of the evidence.

• All cognitive RCTs are small. The Mori and Saitsu trials each recruited 30–31 participants. Sample sizes of this scale cannot support definitive conclusions. Larger, multi-centre trials are needed.
• Benefits require ongoing supplementation. The Mori study clearly demonstrated cognitive scores declined after discontinuation. This appears to be supportive rather than curative.
• No Cochrane systematic review exists. The Cochrane Collaboration — the gold standard for evidence synthesis — has not published a systematic review of lion's mane and cognition. A PRISMA-registered review now exists (PMID: 40959699) but is not Cochrane-level.
• The erinacine A trial used mycelium, not fruiting body. Teelixir's extract uses 100% fruiting body. Hericenones (in fruiting body) and erinacines (in mycelium) both stimulate NGF through different pathways. The mechanistic rationale applies to both, but the specific 49-week Alzheimer's pilot data was generated with mycelium.
• FSANZ has no permitted health claims for lion's mane and cognitive function in Australia. No regulatory approval exists for cognitive claims. The evidence is promising but pre-regulatory.
• Lion's mane is not a substitute for medical assessment. Cognitive decline has many causes — some are readily reversible (thyroid dysfunction, vitamin B12 deficiency, medication side effects, sleep apnoea). These require medical investigation before any supplement is considered.

Practical Guidance for Seniors

Dose and Duration

Clinical trials used 0.8–3 g of lion's mane fruiting body powder daily. Teelixir's organic lion's mane is a 10:1 dual extract, meaning it is more concentrated than the raw powder used in most trials. Starting at 0.5–1 g of extract (equivalent to 5–10 g of raw powder on a 10:1 ratio) and adjusting based on individual response is reasonable. Benefits in the trials appeared at 8 weeks and continued accumulating through 16 weeks — plan for a minimum three-month trial period before assessing effectiveness.

How to Take It

Our extract dissolves easily due to the dual-extraction process. Stir it into warm (not boiling) water, herbal tea, a vegetable broth, or a morning smoothie. Taking it in the morning with food is the most common approach and suits the circadian rhythm of cognitive activity. Some people prefer splitting the dose between morning and midday.

Medication Interactions

Lion's mane has shown mild antiplatelet and immunomodulatory effects in preclinical research. If you or a family member take blood thinners (warfarin, apixaban, aspirin at prescription doses), antiplatelet agents, or immunosuppressants (after organ transplant, for autoimmune conditions), discuss supplementation with your GP or pharmacist before starting. The clinical trial data did not identify significant adverse interactions, but these populations were not specifically studied.

First Step: Medical Assessment

If you are experiencing meaningful cognitive changes — difficulty with word retrieval, getting lost in familiar places, missing appointments, changes in judgement — please see your GP before starting any supplement. Many causes of cognitive decline are treatable, and identifying them promptly matters.

Teelixir Organic Lion's Mane Mushroom

10:1 dual extract · 100% fruiting body · ACO certified organic · 31.7% beta-glucans · No fillers

Shop Lion's Mane

How Lion's Mane Compares to Common Alternatives

Note: This comparison is for general information. We are not recommending against other approaches, and some may be appropriate depending on individual circumstances. Discuss with your GP or pharmacist.

Frequently Asked Questions

Continue Your Research

• Lion's Mane Benefits: What 571 Studies Actually Show
• Lion's Mane for ADHD and Focus: What the Research Actually Shows
• Lion's Mane for Brain Fog: What the Evidence Actually Shows
• Lion's Mane Dosage Guide: Clinical Trial Doses, Extract Conversions & Timing
• Lion's Mane Side Effects: Safety Profile Review
• Lion's Mane for Anxiety: What the Research Actually Shows
• Lion's Mane for Gut Health: The Prebiotic Bridge Your Microbiome Has Been Waiting For
• Lion's Mane for Skin: The Ergothioneine Advantage

← Back to Lion's Mane Research Hub